K. John Morrow, Jr.

K. John Morrow, Jr.

My training is in the field of genetics (PhD, University of Washington, Seattle).  I did post doctoral study at the Istituto di Geneticà, Universitá di Pavia, Italy and the Fox Chase Cancer Center, Philadelphia PA. I have extensive experience in the academic community, including faculty positions at the University of Kansas and the Texas Tech University Health Sciences Center. Currently I am an adjunct faculty member at Northern Kentucky University. I have authored over 60 peer-reviewed publications reporting original research in genetics, immunology, developmental biology, evolution, cancer biology and animal science.

 

 I have been the principal investigator or co-principal investigator on over $2.5M of federal and privately funded research grants, and I was the principal investigator on a small business innovative research grant (SBIR) from the National Institutes of Health to Meridian Biosciences, Inc.

 

In addition to my academic experience, I have been associated with Meridian Bioscience, Inc., an immunodiagnostics firm located in Cincinnati, for the last 15  years. I was first Principle Investigator on a research project supported by the company, and later as Director of Biological Sciences Research at their Cincinnati facility. In addition to my involvement as a research scientist at Meridian, I have consulted for numerous private companies.

 

In 2009 I was awarded a Science Journalism Laureate for excellence in scientific writing from Purdue University.

 

On a personal note, my wife and I share an ancient Italianate Victorian town house in Newport, Kentucky with three cats and enough plants to reverse global warming.

 

  • Morrow discusses biosafety issues with Dorothy Elsaesser, Cincinnati Children's Hospital biosafety officer

About Us

Newport Biotechnology Consultants, founded in 2005, originally was aimed at providing writing expertise in the life sciences industry, with a specialization in molecular immunology. I drew upon my academic and industrial background to cover new developments and technologies in antibody therapies and related areas of biotechnology. These reviews were published in a number of trade journals, especially articles in Genetic Engineering and Biotechnology News (see articles). More recently I have expanded my writing into other fields, including emergency management, drug discovery, bioprocessing, environmental and sustainable technologies, micro- and nanotechnology and many other areas. I also am involved in regulatory issues. I am Chair of the Meridian Bioscience Institutional Biosafety Committee, and I am a member of the Cincinnati Children’s Medical Center Institutional Biosafety Committee (see consulting services). Both IBCs review research protocols dealing with the use of recombinant DNA. Finally, I have consulted for a number of companies on laboratory design, business plan evaluation and regulatory questions.

Videos, Slideshows and Podcasts by Cincopa Wordpress Plugin